Product
Glucagon
11 clinical trials
14 indications
Indication
Cardiovascular DiseasesIndication
Insulin SensitivityIndication
Type 1 DiabetesIndication
Healthy ParticipantsIndication
HypoglycemiaIndication
ObesityIndication
Nonalcoholic Fatty Liver DiseaseIndication
Glucagon ResistanceIndication
Chronic Kidney DiseaseIndication
CirrhosisIndication
hyperglucagonemiaIndication
Type 2 diabetesIndication
NAFLDIndication
Type 1 diabetesClinical trial
A Comparison of the Haemodynamic and Metabolic Effects of Intravenous Glucagon-like Peptide-1, Glucagon and Glucagon-like Peptide-1:Glucagon Co-agonism in Healthy Male ParticipantsStatus: Completed, Estimated PCD: 2021-11-01
Clinical trial
Effect of Physiologic Hyperglucogonemia on Adipocyte MetabolismStatus: Active (not recruiting), Estimated PCD: 2025-12-30
Clinical trial
Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1Status: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation and Pyruvate Carboxylase Flux in Man Assessed by Positional Isotopomer NMR Tracer Analysis (PINTA)Status: Completed, Estimated PCD: 2023-11-01
Clinical trial
Effect of Liver Glycogen Content on Hypoglycemic CounterregulationStatus: Active (not recruiting), Estimated PCD: 2025-05-31
Clinical trial
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese SubjectsStatus: Active (not recruiting), Estimated PCD: 2018-02-14
Clinical trial
The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid TurnoverStatus: Completed, Estimated PCD: 2021-12-09
Clinical trial
The Role of the Kidneys and Liver in the Elimination of Glucagon An Evaluation of the Metabolic Clearance Rate of Glucagon in Patients With End-stage Renal Disease and Patients With Liver CirrhosisStatus: Completed, Estimated PCD: 2023-03-28
Clinical trial
The Effects of Glucagon on Hepatic MetabolismStatus: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
A Pilot Study to Determine Tolerability to Glucagon Infusion in Obese SubjectsStatus: Active (not recruiting), Estimated PCD: 2017-01-13
Clinical trial
Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes - the HypoADAPT StudyStatus: Active (not recruiting), Estimated PCD: 2023-12-01